Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
SINT 
SINTX Technologies Inc (SINT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/24/2025: SINT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -40.94% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/24/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.46M USD | Price to earnings Ratio - | 1Y Target Price 70 |
Price to earnings Ratio - | 1Y Target Price 70 | ||
Volume (30-day avg) 2679546 | Beta 1.2 | 52 Weeks Range 2.01 - 39.20 | Updated Date 04/1/2025 |
52 Weeks Range 2.01 - 39.20 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -15.19 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date 2025-03-24 | When - | Estimate -1.82 | Actual -4.37 |
Profitability
Profit Margin - | Operating Margin (TTM) -248.34% |
Management Effectiveness
Return on Assets (TTM) -39.03% | Return on Equity (TTM) -174.07% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 6891010 | Price to Sales(TTM) 2.24 |
Enterprise Value 6891010 | Price to Sales(TTM) 2.24 | ||
Enterprise Value to Revenue 5.53 | Enterprise Value to EBITDA -0.56 | Shares Outstanding 2515180 | Shares Floating 2265095 |
Shares Outstanding 2515180 | Shares Floating 2265095 | ||
Percent Insiders 9.94 | Percent Institutions 1.62 |
Analyst Ratings
Rating 3 | Target Price 70 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
SINTX Technologies Inc
Company Overview
History and Background
SINTX Technologies, Inc. (formerly Ceradyne, Inc.) was founded in 1996. It focuses on the development and commercialization of silicon nitride for various applications, including biomedical, industrial, and defense.
Core Business Areas
- Biomedical: Development and manufacturing of silicon nitride-based spinal implants and other medical devices.
- Industrial: Utilizing silicon nitride for high-performance industrial applications, such as wear-resistant components.
- Defense: Applying silicon nitride technology in defense-related products and applications.
Leadership and Structure
The leadership team includes a CEO, CFO, and various VPs overseeing different business areas. SINTX operates with a functional organizational structure.
Top Products and Market Share
Key Offerings
- Spinal Implants: Silicon nitride-based spinal fusion devices. Competitors include Medtronic (MDT), Johnson & Johnson (JNJ), and Stryker (SYK). Market share data is not readily available, and revenue data for specific product lines are not publicly disclosed.
- Industrial Components: Silicon nitride components for wear resistance, used in various industrial applications. Competitors are generally material science companies focused on ceramics. Market share is fragmented, and SINTX's specific share is not publicly available.
Market Dynamics
Industry Overview
The markets SINTX operates in (biomedical, industrial ceramics) are growing, driven by aging populations (for biomedical), increasing demand for high-performance materials and industrial applications, and innovation in material science.
Positioning
SINTX positions itself as a materials science innovator, particularly in silicon nitride. Its competitive advantage lies in its proprietary material formulations and manufacturing processes.
Total Addressable Market (TAM)
The combined TAM for SINTX's target markets (spinal implants, industrial ceramics) is estimated to be in the billions of dollars. SINTX's position relative to the TAM is that of a niche player with growth potential if it scales.
Upturn SWOT Analysis
Strengths
- Proprietary silicon nitride technology
- Focus on high-performance applications
- Potential for disruptive innovation in biomedical implants
Weaknesses
- Limited financial resources compared to larger competitors
- Reliance on partnerships for commercialization
- Relatively small market share in competitive markets
Opportunities
- Expanding applications of silicon nitride in new markets
- Strategic partnerships for distribution and manufacturing
- Increasing demand for biocompatible materials in healthcare
Threats
- Competition from established players with greater resources
- Technological advancements in alternative materials
- Regulatory hurdles in the medical device industry
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Johnson & Johnson (JNJ)
- Stryker (SYK)
Competitive Landscape
SINTX faces intense competition from larger, more established players. Its advantage lies in its silicon nitride technology, but it needs to scale up to compete effectively.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are not readily available without access to specific financial data and previous years financial performance.
Future Projections: Future projections are dependent on market conditions and internal strategy and cannot be accurately stated without further research.
Recent Initiatives: Recent strategic initiatives could include new product development, partnerships, or market expansion. Needs more research to be stated accurately.
Summary
SINTX Technologies is a materials science company with a focus on silicon nitride. While its proprietary technology presents a strength, its limited resources and market share are weaknesses. Success depends on capitalizing on growth opportunities through strategic partnerships and expansion into new markets. SINTX needs to navigate a competitive landscape dominated by larger players.
Similar Companies
ALGN
Align Technology Inc
ALGN
Align Technology Inc
JNJ
Johnson & Johnson
JNJ
Johnson & Johnson
MDT
Medtronic PLC
MDT
Medtronic PLC
SYK
Stryker Corporation
SYK
Stryker Corporation
Sources and Disclaimers
Data Sources:
- Company Website
- Public Filings
- Industry Reports
- Analyst Reports
Disclaimers:
Data is based on available information and may be subject to change. Market share figures are estimates and may vary. This analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SINTX Technologies Inc
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2014-02-13 | President, CEO & Chairman of the Board Mr. Eric K. Olson | ||
Sector Healthcare | Industry Medical Devices | Full time employees 20 | Website https://www.sintx.com |
Full time employees 20 | Website https://www.sintx.com | ||
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.